These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12052270)

  • 1. Glycoprotein IIb/IIIa receptor inhibitor-thrombolytic combination therapy for acute myocardial infarction.
    Maranian AM; Steinhubl SR
    Curr Cardiol Rep; 2002 Jul; 4(4):313-9. PubMed ID: 12052270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction.
    Cannon CP
    J Am Coll Cardiol; 1999 Nov; 34(5):1395-402. PubMed ID: 10551684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IIb/IIIa receptor blockade in acute myocardial infarction.
    Ferguson JJ; Taqi K
    Am Heart J; 1999 Aug; 138(2 Pt 2):S164-70. PubMed ID: 10426877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
    Campbell KR; Ohman EM; Cantor W; Lincoff AM
    Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction.
    Ronner E; van Domburg RT; van den Brand MJ; de Feyter PJ; Foley DP; van der Giessen WJ; Serruys PW; Simoons ML
    Eur Heart J; 2002 Oct; 23(19):1529-37. PubMed ID: 12242073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.
    Montalescot G; Borentain M; Payot L; Collet JP; Thomas D
    JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.
    De Luca G; Savonitto S; van't Hof AW; Suryapranata H
    Drugs; 2015 Jul; 75(11):1229-53. PubMed ID: 26177890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction.
    Manoharan G; Adgey AA
    Clin Cardiol; 2004 Jul; 27(7):381-6. PubMed ID: 15298036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction.
    Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G
    Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging the gap with new strategies in acute ST elevation myocardial infarction: bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCI.
    Cannon CP
    J Thromb Thrombolysis; 2000 Apr; 9(3):235-41. PubMed ID: 10728022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary stenting and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction.
    Santoro GM; Bolognese L
    Am Heart J; 2001 Feb; 141(2 Suppl):S26-35. PubMed ID: 11174356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis.
    Cannon CP
    Clin Cardiol; 1999 Aug; 22(8 Suppl):IV37-43. PubMed ID: 10492852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
    Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
    Waters RE; Mahaffey KW; Granger CB; Roe MT
    Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].
    Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B
    Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.
    Russo JJ; Goodman SG; Cantor WJ; Fitchett D; Heffernan M; Borgundvaag B; Ducas J; Cohen EA; Džavik V; Mehta SR; Buller CE; Yan AT;
    Heart; 2014 Jun; 100(11):873-80. PubMed ID: 24449716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
    Bosch X; Marrugat J
    Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.